Aardvark Therapeutics, Inc. (AARD)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 92
-0.18
-2.9508%
After Hours
$
+0.07 +1.1824% 5. 99
126.71M Market Cap
- P/E Ratio
- Div Yield
84,958 Volume
- Eps
$ 6.1
Previous Close Want to track AARD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aardvark Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 77 | $290 | $579.04 | $289.04 | 99.67% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 53 | $202.12 | $381.07 | $178.95 | 88.54% |
 Point72 Asset Management LP Point72 Asset Management LP | 22,872 | $87,828.48 | $149,582.88 | $61,754.4 | 70.31% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 2 | $7.54 | $13.2 | $5.66 | 75.07% |
 Li Peng China Universal Asset Management Co. Ltd. | 3,472 | $42,629.6 | $22,915.2 | -$19,714.4 | -46.25% |
 Drew Phillips Fortitude Family Office LLC | 56 | $215.04 | $369.6 | $154.56 | 71.87% |
 Kevin Kroskey True Wealth Design LLC | 49 | $185 | $323.4 | $138.4 | 74.81% |
 Christopher C. Powers Farther Finance Advisors, LLC | 153 | $585.56 | $1,009.8 | $424.24 | 72.45% |
| JWM JPL Wealth Management LLC JPL Wealth Management, LLC | 7 | $26.88 | $45.78 | $18.9 | 70.31% |
 Ashley Meredith Abel Hall, LLC | 10,066 | $38,653.44 | $66,435.6 | $27,782.16 | 71.87% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 452 | $5,408.28 | $3,570.8 | -$1,837.48 | -33.98% |
